tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CYTO Stock Latest News

Altamira Therapeutics provides update on Nasdaq listing
The FlyAltamira Therapeutics provides update on Nasdaq listing
4d ago
CYTO
Altamira Therapeutics Faces Nasdaq Delisting
PremiumCompany Announcements
Altamira Therapeutics Faces Nasdaq Delisting
5d ago
6K
CYTO
Altamira obtains extended ISO 13485 quality management system certification
PremiumThe Fly
Altamira obtains extended ISO 13485 quality management system certification
12d ago
CYTO
Altamira Therapeutics Reports Narrowed Losses
PremiumCompany Announcements
Altamira Therapeutics Reports Narrowed Losses
15d ago
6K
CYTO
Altamira Therapeutics reports 1H EPS ($2.11) vs. ($21.55) last year
PremiumThe Fly
Altamira Therapeutics reports 1H EPS ($2.11) vs. ($21.55) last year
15d ago
CYTO
Altamira Therapeutics sees FY24 total cash needs $5.8M-$7M
PremiumThe FlyAltamira Therapeutics sees FY24 total cash needs $5.8M-$7M
15d ago
CYTO
Altamira Issues Pre-Funded Share Purchase Warrant
Premium
Company Announcements
Altamira Issues Pre-Funded Share Purchase Warrant
20d ago
6K
CYTO
Altamira Therapeutics announces pricing of $12M offering
Premium
The Fly
Altamira Therapeutics announces pricing of $12M offering
21d ago
CYTO
Altamira announces expansion of Bentrio license, distribution agreement
PremiumThe Fly
Altamira announces expansion of Bentrio license, distribution agreement
23d ago
CYTO
Altamira Therapeutics announces extension of Bentrio distribution agreement
PremiumThe Fly
Altamira Therapeutics announces extension of Bentrio distribution agreement
2M ago
CYTO
Altamira Therapeutics files to sell common stock, warrants, no amount given
PremiumThe Fly
Altamira Therapeutics files to sell common stock, warrants, no amount given
2M ago
CYTO
Altamira Therapeutics announces confirmed suitability of Bentrio for athletes
PremiumThe Fly
Altamira Therapeutics announces confirmed suitability of Bentrio for athletes
2M ago
CYTO
Altamira Therapeutics announces publication of article on Zbtb46 mRNA
PremiumThe FlyAltamira Therapeutics announces publication of article on Zbtb46 mRNA
2M ago
CYTO
Altamira Therapeutics announces publication of preclinical data on SOD2 mRNA
Premium
The Fly
Altamira Therapeutics announces publication of preclinical data on SOD2 mRNA
3M ago
CYTO
Altamira Therapeutics announces publication on betahistine
Premium
The Fly
Altamira Therapeutics announces publication on betahistine
4M ago
CYTO
Altamira Therapeutics announces publication of results from NASAR trial
PremiumThe Fly
Altamira Therapeutics announces publication of results from NASAR trial
5M ago
CYTO
Altamira Shareholders Approve Key Corporate Changes
PremiumCompany Announcements
Altamira Shareholders Approve Key Corporate Changes
5M ago
6K
CYTO
Altamira Therapeutics files provisional patent application for OligoPhore
PremiumThe Fly
Altamira Therapeutics files provisional patent application for OligoPhore
5M ago
CYTO
Altamira Therapeutics announces publication of results from Bentrio trial
PremiumThe Fly
Altamira Therapeutics announces publication of results from Bentrio trial
6M ago
CYTO
Altamira Therapeutics Announces 2024 Annual Meeting
PremiumCompany AnnouncementsAltamira Therapeutics Announces 2024 Annual Meeting
6M ago
6K
CYTO
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
6M ago
ADIL
ALPN
Altamira Therapeutics files to sell 2M common shares for holders
Premium
The Fly
Altamira Therapeutics files to sell 2M common shares for holders
6M ago
CYTO

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >